Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
47.37
-0.26 (-0.55%)
Feb 21, 2025, 4:00 PM EST - Market closed
Merus Market Cap
Merus has a market cap or net worth of $3.24 billion as of February 21, 2025. Its market cap has increased by 55.43% in one year.
Market Cap
3.24B
Enterprise Value
2.47B
1-Year Change
55.43%
Ranking
Category
Stock Price
$47.37
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $3.24B, an increase of 2,167.92%. That is a compound annual growth rate of 42.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.24B | 12.65% |
| Dec 31, 2024 | 2.88B | 81.33% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |